Myeloma

Quest Diagnostics debuts a new blood test for myeloma MRD, offering NGS-level sensitivity and a less invasive alternative to bone marrow biopsies.

Smoldering multiple myeloma is a complex, intermediary stage of plasma cell disorders that requires a nuanced approach to care.

The FDA has granted fast track designation to LBL-034 for patients with relapsed or refractory multiple myeloma.

The FDA approved Darzalex Faspro with Velcade, Revlimid and dexamethasone for newly diagnosed multiple myeloma ineligible for autologous stem cell transplant.

The FDA granted fast track designation to IBI3003 for patients with relapsed/refractory multiple myeloma after receiving four-plus lines of therapy.

CURE sat down with Dr. Surbhi Sidana to discuss this treatment combination and what its approval by the FDA would mean for patients.

Two people have transformed my journey from pain into possibility. In their presence, I find the strength to continue. Together, they've taught me that even in collapse and ill health, life can bloom again.

In patients with relapsed/refractory multiple myeloma, Tecvayli monotherapy is associated with a 71% reduction in the risk of disease progression or death.

Reach out to professionals, go to safe online sources, contact your local cancer support center. I hope these tools help you as they have helped me.

I reflect on a year of healing, family, and meaningful rituals while setting intentions for 2026 with vision, consistency and awakening.

Care partners for multiple myeloma patients emphasize that managing their own mental health is not a luxury, but a necessity for sustainable care.

Living with an incurable cancer that resists durable remission means holding hope and grief at the same time — existing between promising data and lived experience.

Oya Gilbert, diagnosed with multiple myeloma in 2017, advises patients to bring someone to appointments, ask questions and seek second opinions.

Treatment with Lynozyfic showed early responses and a manageable safety profile in patients with newly diagnosed multiple myeloma.

Following a multiple myeloma diagnosis, care partners describe an initial wave of fear and logistical stress.